ACAD Insider Trading

Insider Ownership Percentage: 28.30%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $2,900,421.44

ACADIA Pharmaceuticals Insider Trading History Chart

This chart shows the insider buying and selling history at ACADIA Pharmaceuticals by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

ACADIA Pharmaceuticals Share Price & Price History

Current Price: $16.77
Price Change: Price Decrease of -0.25 (-1.47%)
As of 11/15/2024 01:00 AM ET

This chart shows the closing price history over time for ACAD up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

ACADIA Pharmaceuticals Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
8/19/2024Brendan TeehanCOOSell9,534$15.28$145,679.5252,177View SEC Filing Icon  
8/19/2024Mark C. SchneyerCFOSell9,733$15.28$148,720.2443,735View SEC Filing Icon  
8/19/2024Stephen R. DavisCEOSell31,747$15.28$485,094.16186,555View SEC Filing Icon  
6/10/2024Mark C. SchneyerCFOSell975$14.79$14,420.2534,564View SEC Filing Icon  
5/2/2024Brendan TeehanCOOSell3,477$16.94$58,900.3842,133View SEC Filing Icon  
5/2/2024James KiharaInsiderSell1,326$16.94$22,462.4414,370View SEC Filing Icon  
5/2/2024Mark C. SchneyerCFOSell3,503$16.94$59,340.8232,053View SEC Filing Icon  
5/2/2024Stephen R. DavisCEOSell11,427$16.94$193,573.38155,231View SEC Filing Icon  
4/8/2024Brendan TeehanCOOSell2,568$17.87$45,890.1638,796View SEC Filing Icon  
4/8/2024James KiharaInsiderSell1,790$17.87$31,987.3013,100View SEC Filing Icon  
4/8/2024Mark C. SchneyerCFOSell2,716$17.87$48,534.9228,742View SEC Filing Icon  
4/8/2024Stephen R. DavisCEOSell26,574$17.87$474,877.38144,267View SEC Filing Icon  
3/27/2024Brendan TeehanCOOSell5,140$17.90$92,006.0036,340View SEC Filing Icon  
3/27/2024Mark C. SchneyerCFOSell5,434$17.90$97,268.6026,183View SEC Filing Icon  
3/27/2024Stephen R. DavisCEOSell17,714$17.90$317,080.60118,842View SEC Filing Icon  
2/26/2024Brendan TeehanCOOSell624$24.67$15,394.0831,432View SEC Filing Icon  
2/26/2024James KiharaInsiderSell474$24.67$11,693.5811,391View SEC Filing Icon  
2/26/2024Mark C. SchneyerCFOSell772$24.67$19,045.2421,067View SEC Filing Icon  
2/26/2024Stephen R. DavisCEOSell5,577$24.67$137,584.59101,890View SEC Filing Icon  
1/8/2024Austin D KimEVPSell590$29.96$17,676.4046,901View SEC Filing Icon  
1/8/2024Brendan TeehanCOOSell731$29.96$21,900.7630,949View SEC Filing Icon  
1/8/2024Stephen R. DavisCEOSell3,732$29.96$111,810.7296,521View SEC Filing Icon  
12/15/2023James KiharaInsiderSell2,000$28.30$56,600.0011,025View SEC Filing Icon  
11/20/2023Brendan TeehanCOOSell4,960$22.64$112,294.4030,393View SEC Filing Icon  
11/20/2023James KiharaInsiderSell1,985$22.64$44,940.4013,025View SEC Filing Icon  
11/20/2023Mark C. SchneyerCFOSell5,108$22.64$115,645.1220,486View SEC Filing Icon  
10/6/2023Austin D KimEVPSell16,369$21.96$359,463.2445,857View SEC Filing Icon  
10/6/2023Stephen R. DavisCEOSell51,563$21.96$1,132,323.4889,131View SEC Filing Icon  
9/15/2023James KiharaInsiderSell2,000$25.88$51,760.0010,778View SEC Filing Icon  
8/21/2023Mark C. SchneyerCFOSell10,000$29.00$290,000.0015,682View SEC Filing Icon  
7/14/2023Stephen R. DavisCEOSell100,000$30.04$3,004,000.0036,695View SEC Filing Icon  
7/11/2023Stephen R. DavisCEOSell16,498$25.00$412,450.0091,799View SEC Filing Icon  
6/15/2023James KiharaInsiderSell2,000$24.15$48,300.009,144View SEC Filing Icon  
6/12/2023Laura BregeDirectorSell4,500$24.87$111,915.0013,502View SEC Filing Icon  
6/8/2023Mark C. SchneyerCFOSell974$25.02$24,369.4822,824View SEC Filing Icon  
5/23/2023Bros. Advisors Lp BakerDirectorBuy209,053$25.41$5,312,036.7338,811,515View SEC Filing Icon  
5/17/2023Brendan TeehanCOOSell14,869$22.50$334,552.5024,356View SEC Filing Icon  
5/17/2023James KiharaInsiderSell5,947$22.50$133,807.5011,144View SEC Filing Icon  
5/17/2023Mark C. SchneyerCFOSell15,310$22.50$344,475.0021,905View SEC Filing Icon  
5/1/2023Austin D KimEVPSell917$21.18$19,422.0625,513View SEC Filing Icon  
5/1/2023Brendan TeehanCOOSell548$21.18$11,606.649,487View SEC Filing Icon  
5/1/2023Stephen R. DavisCEOSell7,806$21.18$165,331.08108,297View SEC Filing Icon  
4/10/2023James KiharaInsiderSell523$18.14$9,487.225,197View SEC Filing Icon  
4/6/2023Austin D KimEVPSell1,456$18.16$26,440.9623,425View SEC Filing Icon  
4/6/2023Brendan TeehanCOOSell1,751$18.16$31,798.168,468View SEC Filing Icon  
4/6/2023James KiharaInsiderSell701$18.16$12,730.164,231View SEC Filing Icon  
4/6/2023Mark C. SchneyerCFOSell1,916$18.16$34,794.567,477View SEC Filing Icon  
4/6/2023Stephen R. DavisCEOSell8,582$18.16$155,849.12100,478View SEC Filing Icon  
2/24/2023Austin D KimEVPSell803$18.78$15,080.3420,108View SEC Filing Icon  
2/24/2023Brendan TeehanCOOSell461$18.78$8,657.585,195View SEC Filing Icon  
2/24/2023James KiharaInsiderSell350$18.78$6,573.002,923View SEC Filing Icon  
2/24/2023Mark C. SchneyerCFOSell577$18.78$10,836.064,118View SEC Filing Icon  
2/24/2023Stephen R. DavisCEOSell3,851$18.78$72,321.7891,727View SEC Filing Icon  
1/12/2023Laura BregeDirectorSell12,500$18.25$228,125.00View SEC Filing Icon  
1/9/2023Austin D KimEVPSell589$17.13$10,089.5718,697View SEC Filing Icon  
1/9/2023Brendan TeehanCOOSell532$17.13$9,113.164,549View SEC Filing Icon  
1/9/2023Stephen R. DavisCEOSell3,904$17.13$66,875.5284,633View SEC Filing Icon  
11/21/2022Srdjan R StankovicPresidentSell1,847$15.07$27,834.2961,234View SEC Filing Icon  
10/15/2022Srdjan R StankovicPresidentSell1,326$15.81$20,964.0656,831View SEC Filing Icon  
10/15/2022Stephen R. DavisCEOSell2,804$15.81$44,331.2479,009View SEC Filing Icon  
6/9/2022Mark C. SchneyerCFOSell653$17.91$11,695.233,342View SEC Filing Icon  
5/2/2022Austin D KimEVPSell894$18.18$16,252.9216,742View SEC Filing Icon  
5/2/2022Brendan TeehanCOOSell552$18.18$10,035.363,437View SEC Filing Icon  
5/2/2022Srdjan R StankovicPresidentSell2,865$18.18$52,085.7055,188View SEC Filing Icon  
5/2/2022Stephen R. DavisCEOSell5,483$18.18$99,680.9475,875View SEC Filing Icon  
4/8/2022James KiharainsiderSell1,025$27.05$27,726.252,433View SEC Filing Icon  
2/23/2022Austin D KimEVPSell782$23.80$18,611.60View SEC Filing Icon  
2/23/2022Brendan TeehanCOOSell472$23.80$11,233.60View SEC Filing Icon  
2/23/2022James KiharaInsiderSell359$23.80$8,544.20View SEC Filing Icon  
2/23/2022Srdjan R StankovicPresidentSell1,501$23.80$35,723.80View SEC Filing Icon  
2/23/2022Stephen R. DavisCEOSell3,928$23.80$93,486.40View SEC Filing Icon  
11/22/2021Srdjan R StankovicPresidentSell2,803$19.01$53,285.03View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for ACADIA Pharmaceuticals (NASDAQ:ACAD)

96.71% of ACADIA Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at ACAD by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

ACADIA Pharmaceuticals Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/15/2024Iron Triangle Partners LP750,000$11.54M1.6%N/A0.451%Search for SEC Filing on Google Icon
11/15/2024Jacobs Levy Equity Management Inc.1,211,314$18.63M0.1%-10.6%0.728%Search for SEC Filing on Google Icon
11/15/2024Cinctive Capital Management LP39,040$0.60M0.0%-12.0%0.023%Search for SEC Filing on Google Icon
11/15/2024Erste Asset Management GmbH242,300$3.80M0.0%N/A0.146%Search for SEC Filing on Google Icon
11/14/2024Edgestream Partners L.P.219,329$3.37M0.1%+141.1%0.132%Search for SEC Filing on Google Icon
11/14/2024PDT Partners LLC13,218$0.20M0.0%N/A0.008%Search for SEC Filing on Google Icon
11/14/2024Fred Alger Management LLC3,186,389$49.01M0.2%+17.8%1.915%Search for SEC Filing on Google Icon
11/14/2024Eventide Asset Management LLC577,500$8.88M0.2%N/A0.347%Search for SEC Filing on Google Icon
11/14/2024Rockefeller Capital Management L.P.1,139,934$17.53M0.0%+19.5%0.685%Search for SEC Filing on Google Icon
11/14/2024Walleye Capital LLC40,806$0.63M0.0%-64.6%0.025%Search for SEC Filing on Google Icon
11/14/2024UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC189,739$2.92M0.0%-12.8%0.114%Search for SEC Filing on Google Icon
11/14/2024Stonepine Capital Management LLC196,895$3.03M1.9%+3,837.9%0.118%Search for SEC Filing on Google Icon
11/13/2024BNP Paribas Financial Markets223,618$3.44M0.0%+259.0%0.134%Search for SEC Filing on Google Icon
11/13/2024FMR LLC97,358$1.50M0.0%-95.9%0.059%Search for SEC Filing on Google Icon
11/13/2024Advantage Alpha Capital Partners LP24,914$0.38M0.1%-34.6%0.015%Search for SEC Filing on Google Icon
11/13/2024The Manufacturers Life Insurance Company 413,269$6.36M0.0%-10.6%0.248%Search for SEC Filing on Google Icon
11/13/2024Dynamic Technology Lab Private Ltd22,229$0.34M0.0%N/A0.013%Search for SEC Filing on Google Icon
11/13/2024Fisher Asset Management LLC194,599$2.99M0.0%+19.7%0.117%Search for SEC Filing on Google Icon
11/12/2024Algert Global LLC549,456$8.45M0.2%+2.9%0.331%Search for SEC Filing on Google Icon
11/12/2024Charles Schwab Investment Management Inc.1,271,135$19.55M0.0%-0.3%0.766%Search for SEC Filing on Google Icon
11/12/2024Massachusetts Financial Services Co. MA61,051$0.94M0.0%-2.4%0.037%Search for SEC Filing on Google Icon
11/9/2024Landscape Capital Management L.L.C.16,562$0.26M0.0%N/A0.010%Search for SEC Filing on Google Icon
11/9/2024Intech Investment Management LLC37,683$0.58M0.0%N/A0.023%Search for SEC Filing on Google Icon
11/8/2024Advisors Asset Management Inc.21,087$0.32M0.0%+13.4%0.013%Search for SEC Filing on Google Icon
11/8/2024Connor Clark & Lunn Investment Management Ltd.972,665$14.96M0.1%-22.4%0.586%Search for SEC Filing on Google Icon
11/8/2024B. Metzler seel. Sohn & Co. Holding AG31,405$0.48M0.0%N/A0.019%Search for SEC Filing on Google Icon
11/8/2024Phocas Financial Corp.60,215$0.93M0.0%-5.9%0.036%Search for SEC Filing on Google Icon
11/7/2024Quest Partners LLC3,520$54K0.0%+42.3%0.002%Search for SEC Filing on Google Icon
11/6/2024Natixis Advisors LLC40,488$0.62M0.0%+58.6%0.024%Search for SEC Filing on Google Icon
11/6/2024Oppenheimer Asset Management Inc.37,429$0.58M0.0%+26.6%0.023%Search for SEC Filing on Google Icon
11/5/2024Victory Capital Management Inc.97,130$1.49M0.0%+2.9%0.059%Search for SEC Filing on Google Icon
11/5/2024GSA Capital Partners LLP67,096$1.03M0.1%-62.9%0.040%Search for SEC Filing on Google Icon
11/5/2024WCM Investment Management LLC286,527$4.50M0.0%-1.0%0.173%Search for SEC Filing on Google Icon
11/4/2024Los Angeles Capital Management LLC44,297$0.68M0.0%-13.1%0.027%Search for SEC Filing on Google Icon
11/1/2024Atria Investments Inc24,437$0.38M0.0%+10.8%0.015%Search for SEC Filing on Google Icon
10/31/2024Principal Financial Group Inc.129,551$1.99M0.0%+67.8%0.078%Search for SEC Filing on Google Icon
10/30/2024AlphaCentric Advisors LLC40,000$0.62M0.5%-60.0%0.024%Search for SEC Filing on Google Icon
10/29/2024Emerald Advisers LLC830,829$12.78M0.5%+2.7%0.503%Search for SEC Filing on Google Icon
10/29/2024Emerald Mutual Fund Advisers Trust574,810$8.84M0.5%+2.9%0.348%Search for SEC Filing on Google Icon
10/28/2024Rice Hall James & Associates LLC717,146$11.03M0.6%-3.5%0.434%Search for SEC Filing on Google Icon
10/28/2024US Bancorp DE32,934$0.51M0.0%+2,084.0%0.020%Search for SEC Filing on Google Icon
10/25/2024China Universal Asset Management Co. Ltd.31,903$0.49M0.1%+64.4%0.019%Search for SEC Filing on Google Icon
10/23/2024Mirae Asset Global Investments Co. Ltd.5,999$94K0.0%+21.6%0.004%Search for SEC Filing on Google Icon
10/23/2024Garrison Point Advisors LLC10,576$0.16M0.1%N/A0.006%Search for SEC Filing on Google Icon
10/23/2024Values First Advisors Inc.1,754$27K0.0%N/A0.001%Search for SEC Filing on Google Icon
10/23/2024Hennion & Walsh Asset Management Inc.95,834$1.47M0.1%-6.5%0.058%Search for SEC Filing on Google Icon
10/19/2024Allspring Global Investments Holdings LLC121,625$1.87M0.0%+11.7%0.074%Search for SEC Filing on Google Icon
10/11/2024Creative Planning25,061$0.39M0.0%+71.4%0.015%Search for SEC Filing on Google Icon
10/8/2024Park Place Capital Corp1,600$25K0.0%N/A0.001%Search for SEC Filing on Google Icon
10/5/2024Handelsbanken Fonder AB47,633$0.73M0.0%+16.7%0.029%Search for SEC Filing on Google Icon
10/3/2024SG Americas Securities LLC517,124$7.95M0.0%+419.8%0.313%Search for SEC Filing on Google Icon
9/20/2024Healthcare of Ontario Pension Plan Trust Fund70,524$1.15M0.0%-62.7%0.043%Search for SEC Filing on Google Icon
9/16/2024Point72 Asia Singapore Pte. Ltd.4,538$74K0.0%-72.5%0.003%Search for SEC Filing on Google Icon
9/5/2024Sanctuary Advisors LLC91,834$1.54M0.0%N/A0.056%Search for SEC Filing on Google Icon
8/21/2024Truist Financial Corp50,006$0.81M0.0%+16.0%0.030%Search for SEC Filing on Google Icon
8/21/2024Stonepine Capital Management LLC5,000$81K0.1%N/A0.003%Search for SEC Filing on Google Icon
8/16/2024Quarry LP8,055$0.13M0.0%+34.3%0.005%Search for SEC Filing on Google Icon
8/16/2024Capital Impact Advisors LLC24,540$0.40M1.1%+153.4%0.015%Search for SEC Filing on Google Icon
8/16/2024Algert Global LLC534,143$8.68M0.3%+50.7%0.323%Search for SEC Filing on Google Icon
8/16/2024Cim Investment Management Inc.15,082$0.25M0.1%-19.2%0.009%Search for SEC Filing on Google Icon
8/15/2024Scientech Research LLC41,586$0.68M0.1%N/A0.025%Search for SEC Filing on Google Icon
8/15/2024Mackenzie Financial Corp19,900$0.32M0.0%-65.5%0.012%Search for SEC Filing on Google Icon
8/15/2024The Manufacturers Life Insurance Company462,078$7.51M0.0%-60.6%0.280%Search for SEC Filing on Google Icon
8/15/2024Millennium Management LLC2,937,714$47.74M0.0%+36.2%1.778%Search for SEC Filing on Google Icon
8/15/2024D. E. Shaw & Co. Inc.2,934,926$47.69M0.0%+11.1%1.776%Search for SEC Filing on Google Icon
8/15/2024Dark Forest Capital Management LP32,910$0.54M0.1%N/A0.020%Search for SEC Filing on Google Icon
8/15/2024AQR Capital Management LLC36,191$0.59M0.0%-23.9%0.022%Search for SEC Filing on Google Icon
8/15/2024Point72 Asia Singapore Pte. Ltd.4,538$74K0.0%-72.5%0.003%Search for SEC Filing on Google Icon
8/15/2024Point72 Europe London LLP50,600$0.82M0.1%N/A0.031%Search for SEC Filing on Google Icon
8/14/2024Squarepoint Ops LLC848,441$13.79M0.0%-14.2%0.514%Search for SEC Filing on Google Icon
8/14/2024Fred Alger Management LLC2,704,439$43.95M0.2%+19.8%1.637%Search for SEC Filing on Google Icon
8/14/2024Cubist Systematic Strategies LLC666,578$10.83M0.1%+47.6%0.402%Search for SEC Filing on Google Icon
8/14/2024Marshall Wace LLP2,774,353$45.08M0.1%+431.1%1.679%Search for SEC Filing on Google Icon
8/14/2024Bank of Montreal Can96,225$1.57M0.0%N/A0.058%Search for SEC Filing on Google Icon
8/14/2024HighVista Strategies LLC25,878$0.42M0.2%N/A0.016%Search for SEC Filing on Google Icon
8/14/2024ProShare Advisors LLC26,626$0.43M0.0%-20.7%0.016%Search for SEC Filing on Google Icon
8/14/2024Profund Advisors LLC56,555$0.92M0.0%-8.7%0.034%Search for SEC Filing on Google Icon
8/13/2024Thrivent Financial for Lutherans78,292$1.27M0.0%-4.1%0.047%Search for SEC Filing on Google Icon
8/13/2024Sei Investments Co.32,734$0.53M0.0%-5.8%0.020%Search for SEC Filing on Google Icon
8/13/2024Canada Pension Plan Investment Board738,700$12M0.0%+11.7%0.447%Search for SEC Filing on Google Icon
8/13/2024Public Employees Retirement Association of Colorado13,821$0.23M0.0%-9.9%0.008%Search for SEC Filing on Google Icon
8/12/2024XTX Topco Ltd36,520$0.59M0.1%N/A0.022%Search for SEC Filing on Google Icon
8/9/2024Edgestream Partners L.P.90,957$1.48M0.1%+46.9%0.055%Search for SEC Filing on Google Icon
8/9/2024Renaissance Technologies LLC476,000$7.74M0.0%-17.0%0.288%Search for SEC Filing on Google Icon
8/9/2024Dimensional Fund Advisors LP649,150$10.55M0.0%N/A0.393%Search for SEC Filing on Google Icon
8/9/2024Massachusetts Financial Services Co. MA62,530$1.02M0.0%+3.5%0.038%Search for SEC Filing on Google Icon
8/8/2024Envestnet Asset Management Inc.107,543$1.75M0.0%+1.9%0.065%Search for SEC Filing on Google Icon
8/8/2024Oppenheimer Asset Management Inc.29,557$0.48M0.0%+10.6%0.018%Search for SEC Filing on Google Icon
8/8/2024Jupiter Asset Management Ltd.1,060,840$17.24M0.2%-33.9%0.642%Search for SEC Filing on Google Icon
8/8/2024American Century Companies Inc.73,148$1.19M0.0%+76.7%0.044%Search for SEC Filing on Google Icon
8/8/2024Rice Hall James & Associates LLC742,935$12.07M0.7%+11.8%0.450%Search for SEC Filing on Google Icon
8/7/2024Headlands Technologies LLC57,209$0.93M0.1%+2,099.5%0.035%Search for SEC Filing on Google Icon
8/7/2024Van Hulzen Asset Management LLC91,485$1.49M0.1%+18.4%0.055%Search for SEC Filing on Google Icon
8/6/2024Quest Partners LLC2,473$40K0.0%-73.2%0.001%Search for SEC Filing on Google Icon
8/6/2024Emerald Advisers LLC808,831$13.14M0.6%-51.0%0.490%Search for SEC Filing on Google Icon
8/6/2024Acadian Asset Management LLC6,884$0.11M0.0%N/A0.004%Search for SEC Filing on Google Icon
8/6/2024Emerald Mutual Fund Advisers Trust558,849$9.08M0.5%-55.3%0.338%Search for SEC Filing on Google Icon
8/6/2024Los Angeles Capital Management LLC50,969$0.83M0.0%-24.5%0.031%Search for SEC Filing on Google Icon
8/5/2024Arizona State Retirement System29,983$0.49M0.0%+2.2%0.018%Search for SEC Filing on Google Icon
8/5/2024Victory Capital Management Inc.94,422$1.53M0.0%+18.4%0.057%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
ACADIA Pharmaceuticals logo
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization innovative medicines that address unmet medical needs in central nervous system (CNS) disorders and rare diseases in the United States. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis; and DAYBUE, a novel synthetic analog of the amino-terminal tripeptide of insulin-like growth factor 1 for treatment of Rett Syndrome. It also develops Pimavanserin that is in Phase III ADVANCE-2 study to treat the negative symptoms of schizophrenia; ACP-101 whixh is in Phase III for the treatment of hyperphagia in Prader-Willi syndrome; ACP-204 which is in Phase II for the treatment of Alzheimer's disease psychosis; ACP-2591 that is in Phase I for Rett syndrome and Fragile X syndrome; preclinical antisense oligonucleotide programs; and other programs for neuropsychiatric symptoms. It has a license agreement with Neuren Pharmaceuticals Limited to develop and commercialize trofinetide for Rett syndrome and other indications; and a license and collaboration agreement with Stoke Therapeutics, Inc. to discover, develop and commercialize novel RNA-based medicines for the potential treatment of severe and rare genetic neurodevelopmental diseases of the CNS. The company was formerly known as Receptor Technologies, Inc. and changed its name ACADIA Pharmaceuticals Inc. in 1997. ACADIA Pharmaceuticals Inc. was incorporated in 1993 and is headquartered in San Diego, California.
Read More on ACADIA Pharmaceuticals

Today's Range

Now: $16.77
Low: $16.37
High: $17.30

50 Day Range

MA: $15.55
Low: $14.29
High: $18.27

52 Week Range

Now: $16.77
Low: $14.15
High: $32.59

Volume

1,826,798 shs

Average Volume

1,681,694 shs

Market Capitalization

$2.79 billion

P/E Ratio

21.50

Dividend Yield

N/A

Beta

0.38

Who are the company insiders with the largest holdings of ACADIA Pharmaceuticals?

ACADIA Pharmaceuticals' top insider investors include:
  1. Bros Advisors Lp Baker (Director)
  2. Stephen Davis (CEO)
  3. Srdjan R Stankovic (President)
  4. Brendan Teehan (COO)
  5. Austin D Kim (EVP)
  6. Mark C Schneyer (CFO)
  7. James Kihara (Insider)
  8. Laura Brege (Director)
Learn More about top insider investors at ACADIA Pharmaceuticals.

Who are the major institutional investors of ACADIA Pharmaceuticals?

ACADIA Pharmaceuticals' top institutional shareholders include:
  1. State Street Corp — 3.59%
  2. Fred Alger Management LLC — 1.91%
  3. Charles Schwab Investment Management Inc. — 0.77%
  4. Jacobs Levy Equity Management Inc. — 0.73%
  5. Rockefeller Capital Management L.P. — 0.69%
  6. Connor Clark & Lunn Investment Management Ltd. — 0.59%
Learn More about top institutional investors of ACADIA Pharmaceuticals stock.

Which institutional investors are selling ACADIA Pharmaceuticals stock?

In the last quarter, ACAD stock was sold by these institutional investors:
  1. FMR LLC
  2. Connor Clark & Lunn Investment Management Ltd.
  3. Jacobs Levy Equity Management Inc.
  4. GSA Capital Partners LLP
  5. Sphera Funds Management LTD.
  6. Walleye Capital LLC
  7. AlphaCentric Advisors LLC
  8. The Manufacturers Life Insurance Company
During the previous year, company insiders that have sold ACADIA Pharmaceuticals company stock include:
  1. Bros Advisors Lp Baker (Director)
  2. Stephen Davis (CEO)
  3. Srdjan R Stankovic (President)
  4. Brendan Teehan (COO)
  5. Austin D Kim (EVP)
Learn More investors selling ACADIA Pharmaceuticals stock.

Which institutional investors are buying ACADIA Pharmaceuticals stock?

During the previous quarter, ACAD stock was purchased by institutional investors including:
  1. Iron Triangle Partners LP
  2. Eventide Asset Management LLC
  3. Fred Alger Management LLC
  4. SG Americas Securities LLC
  5. Erste Asset Management GmbH
  6. Stonepine Capital Management LLC
  7. Rockefeller Capital Management L.P.
  8. State Street Corp